Chengcheng Guo

838 total citations
48 papers, 508 citations indexed

About

Chengcheng Guo is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Chengcheng Guo has authored 48 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Genetics and 10 papers in Oncology. Recurrent topics in Chengcheng Guo's work include Glioma Diagnosis and Treatment (14 papers), Lymphoma Diagnosis and Treatment (7 papers) and Brain Metastases and Treatment (6 papers). Chengcheng Guo is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Lymphoma Diagnosis and Treatment (7 papers) and Brain Metastases and Treatment (6 papers). Chengcheng Guo collaborates with scholars based in China, United States and Netherlands. Chengcheng Guo's co-authors include Hongqiang Guo, Guoliang Huang, Tong-Yu Lin, Xingxiang Pu, Zhongping Chen, Xuan Dong, Jie Huang, Hailiang Wang, Wenchao Wang and Tongyu Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Chengcheng Guo

47 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengcheng Guo China 13 195 143 116 102 64 48 508
Sabrina Engelhardt Switzerland 6 148 0.8× 95 0.7× 71 0.6× 48 0.5× 18 0.3× 7 404
Marie Chanal France 11 136 0.7× 134 0.9× 32 0.3× 115 1.1× 13 0.2× 47 497
Marcel O. Schmidt United States 16 274 1.4× 44 0.3× 74 0.6× 95 0.9× 8 0.1× 37 529
Marianne Dutaur France 10 214 1.1× 161 1.1× 35 0.3× 65 0.6× 15 0.2× 10 533
Hiroshi Kamiguchi Japan 11 261 1.3× 30 0.2× 147 1.3× 32 0.3× 11 0.2× 30 463
Jianming Yang China 11 145 0.7× 52 0.4× 67 0.6× 43 0.4× 5 0.1× 23 341
Jianxin Li China 11 185 0.9× 26 0.2× 78 0.7× 47 0.5× 5 0.1× 40 386
Şenay Balcı Türkiye 9 236 1.2× 59 0.4× 212 1.8× 17 0.2× 14 0.2× 31 442
Maryam Kheirandish Iran 10 141 0.7× 59 0.4× 45 0.4× 53 0.5× 6 0.1× 40 399

Countries citing papers authored by Chengcheng Guo

Since Specialization
Citations

This map shows the geographic impact of Chengcheng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengcheng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengcheng Guo more than expected).

Fields of papers citing papers by Chengcheng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengcheng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengcheng Guo. The network helps show where Chengcheng Guo may publish in the future.

Co-authorship network of co-authors of Chengcheng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chengcheng Guo. A scholar is included among the top collaborators of Chengcheng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengcheng Guo. Chengcheng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Amakye, William Kwame, Zhenzhen Xu, Min Wang, et al.. (2023). Soypeptide supplementation attenuates weight loss and improves quality of life among brain cancer patients in a pilot study. SHILAP Revista de lepidopterología. 4(3). 1298–1310. 1 indexed citations
5.
Guo, Chengcheng, et al.. (2023). A novel lactate dehydrogenase-based risk score model to predict the prognosis of primary central nervous system germ cell tumor treated with chemoradiotherapy. Clinical Neurology and Neurosurgery. 236. 108081–108081. 1 indexed citations
6.
Li, Zonglin, Fang Lv, Chengcheng Guo, et al.. (2023). Dapagliflozin Treatment and Cardiovascular Outcome in RBP4/TTRVal30Met (Transthyretin Cardiac Amyloidosis) Mice. ESC Heart Failure. 11(1). 179–188. 3 indexed citations
7.
8.
Guo, Chengcheng, et al.. (2021). Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta‐analysis. Cancer Medicine. 10(22). 7895–7908. 7 indexed citations
9.
Guo, Chengcheng, Zhihui Yü, Wei-Chi Wu, et al.. (2020). Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma. Cancer Chemotherapy and Pharmacology. 86(6). 773–782. 22 indexed citations
10.
Chen, Zhongping, De‐Pei Li, Yinsheng Chen, et al.. (2019). Real-world management and survival outcomes of patients with newly diagnosed gliomas from a single institution in China: A retrospective cohort study. SHILAP Revista de lepidopterología. 2(2). 96–96. 4 indexed citations
12.
Guo, Chengcheng, et al.. (2016). Clinical significance of B7-H6 protein expression in astrocytoma. OncoTargets and Therapy. 9. 3291–3291. 16 indexed citations
13.
Chen, Zhongping, Qunying Yang, & Chengcheng Guo. (2015). Profile of nimotuzumab in the treatment of high-grade glioma. OncoTargets and Therapy. 8. 819–819. 15 indexed citations
14.
Huang, He, Chengcheng Guo, Shanshan Li, et al.. (2015). Predictive Value of Interim 18 f-FDG PET-CT Scans on Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Study. Blood. 126(23). 1458–1458. 3 indexed citations
15.
Liu, Xiao, Zhengzheng Zhang, Xianliang Yan, et al.. (2014). The Rho kinase inhibitor Y-27632 facilitates the differentiation of bone marrow mesenchymal stem cells. Journal of Molecular Histology. 45(6). 707–714. 18 indexed citations
16.
Lin, Tongyu, Huangming Hong, He Huang, et al.. (2014). Extranodal natural killer T-cell lymphoma, nasal-type—A new staging system from CSWOG—A multicenter study.. Journal of Clinical Oncology. 32(15_suppl). 8552–8552. 3 indexed citations
17.
Guo, Chengcheng, Haibo Lu, Wen Gao, et al.. (2013). Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival. PLoS ONE. 8(9). e74973–e74973. 39 indexed citations
18.
Guo, Chengcheng, Ruping Shao, Arlene M. Correa, et al.. (2013). Prognostic Significance of Combinations of RNA-Dependent Protein Kinase and EphA2 Biomarkers for NSCLC. Journal of Thoracic Oncology. 8(3). 301–308. 19 indexed citations
19.
He, Yong, Zhen Zhou, Wayne L. Hofstetter, et al.. (2012). Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters. PLoS ONE. 7(2). e31087–e31087. 33 indexed citations
20.
Guo, Chengcheng, Yabing Cao, Jian Xiao, et al.. (2009). Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin’s lymphoma: single center, 15-year experience. International Journal of Hematology. 91(1). 78–86. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026